These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2659500)

  • 1. Cellular responses to "brucelline INRA" during the experimental brucellosis of the mouse.
    Bureau JP; Caravano R; Garelli L; Lemaire J
    Immunobiology; 1989 Mar; 179(1):8-16. PubMed ID: 2659500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulating activity of Brucella fractions in a human lymphocyte transformation test. Correlation with humoral and cellular immunity.
    Bascoul S; Peraldi M; Merino AL; Lacave C; Cannat A; Serre A
    Immunology; 1976 Nov; 31(5):717-22. PubMed ID: 992708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The cell wall fractions of Brucella are specific mitogens. Implications in the genesis of the primary immune response].
    Renoux M; Renoux G; Néhémie C
    C R Seances Soc Biol Fil; 1977; 171(1):248-52. PubMed ID: 143325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mitogenic activity of Brucella fractions on cultured lymphocytes].
    Renoux M; Renoux G; Palat A; Néhémie C
    Dev Biol Stand; 1976; 31():230-4. PubMed ID: 770221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological control of the brucellin INRA in sensitized guinea pigs: a guide for the statistical analysis of results].
    de Reviers M; Fensterbank R
    Ann Rech Vet; 1984; 15(3):395-403. PubMed ID: 6517480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killing of Brucella antigen-sensitized macrophages by T lymphocytes in bovine brucellosis.
    Wyckoff JH; Potts RD
    Vet Immunol Immunopathol; 2007 Dec; 120(3-4):148-59. PubMed ID: 17904229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH; Rich RR; Smith TK
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of the badger (Meles meles) to infection with Brucella abortus.
    Corbel MJ; Morris JA; Thorns CJ; Redwood DW
    Res Vet Sci; 1983 May; 34(3):296-300. PubMed ID: 6410474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of BALB/c mice against Brucella melitensis 16 M infection induced by vaccination with live Escherchia coli expression Brucella P39 protein.
    Al-Mariri A
    Vaccine; 2010 Feb; 28(7):1766-70. PubMed ID: 20036752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophages and Brucella.
    Baldwin CL; Winter AJ
    Immunol Ser; 1994; 60():363-80. PubMed ID: 8251581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brucella ribosomal protein L7/L12 is a major component in the antigenicity of brucellin INRA for delayed-type hypersensitivity in brucella-sensitized guinea pigs.
    Bachrach G; Banai M; Bardenstein S; Hoida G; Genizi A; Bercovier H
    Infect Immun; 1994 Dec; 62(12):5361-6. PubMed ID: 7960115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between macrophage migration inhibition and immunity to Brucella abortus in guinea-pigs.
    Cameron CM; Van Rensburg JJ; Engelbrecht MM
    Onderstepoort J Vet Res; 1976 Dec; 43(4):175-84. PubMed ID: 828715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-enhanced glucosamine incorporation by peritoneal macrophages in cell-mediated hypersensitivity. I. Studies on biology and mechanism.
    Hammond ME; Selvaggio SS; Dvorak HF
    J Immunol; 1975 Oct; 115(4):914-21. PubMed ID: 1100724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Practical value of examining cellular immunity in human brucellosis].
    Bertrand A; Siffert M; Bascoul S; Mathieu-Daudé JC
    Dev Biol Stand; 1984; 56():537-46. PubMed ID: 6489630
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
    Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response in rams experimentally infected with Brucella ovis.
    Afzal M; Tengerdy RP; Brodie SJ; Demartini JC; Ellis RP; Jones RL; Kimberling CV
    Res Vet Sci; 1986 Jul; 41(1):85-9. PubMed ID: 3764107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
    Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P
    Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro nonspecific mitogenic response of T-cell subsets in acute and chronic brucellosis.
    Kinikli S; Turkcapar N; Kucukay MB; Keskin G; Kinikli G
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):229-33. PubMed ID: 15893904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.